A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer
Wendy W. Hu, Gwynn D. Long, Keith E. Stockerl-Goldstein, Laura J. Johnston, Nelson J. Chao, Robert S. Negrin, Karl G. Blume
Dive into the research topics of 'A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer'. Together they form a unique fingerprint.